Study analysis · Frontiers in Cellular and Infection Microbiology · 2023
Your gut bacteria might be brewing alcohol that damages your liver, even if you don't drink.
People with severe fatty liver disease have more alcohol in their stool and certain bacteria that produce it.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at people with a liver disease called NASH and healthy people. They found that the sick people had more ethanol in their poop and more bacteria that make ethanol. But this type of study can only show that these things are linked; it can't prove that the bacteria cause the disease.
What’s the bottom line?
Scientists studied poop from people with a liver disease called NASH and healthy people. They found that NASH patients have more alcohol (ethanol) in their stool, and certain bacteria that make alcohol are more common in NASH patients.
How strong is this study?
The study compared two groups and used two different methods to find bacteria, which is good. But it only looked at people once, so we don't know what came first. Also, the group with NASH was small, and the healthy group might not have been perfectly healthy. So we should be careful about trusting the results too much.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
26 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=65)+5.5/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 543 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. Case-control studies can only identify associations, not causal relationships, due to lack of randomization, potential confounding, and inability to establish temporal sequence.
COI Unknown
Could not determine conflict of interest status
No funding or conflict of interest information provided in the text.
The text does not include a funding statement or conflict of interest declaration. Without this information, it is not possible to assess potential biases.
Key takeaways
- 01
NASH patients had higher stool alcohol levels (11 out of 41 had abnormal levels vs 0 in controls).
- 02
Four alcohol-making bacteria were found more often in NASH patients.
- 03
This suggests that gut bacteria producing alcohol might contribute to liver damage in NASH.
Surprising findings
- Enterocloster bolteae was detected only by culturomics, not by standard 16S sequencing.It challenges the assumption that DNA sequencing is enough to identify all important microbes, showing old-school culture methods are still essential.
- Lacticaseibacillus casei was never found in NASH patients, but was in 30% of controls.This common probiotic might have a protective role, which is the opposite of the harmful bacteria typically associated with disease.
Practical takeaways
Consider taking probiotics containing Lacticaseibacillus casei if you have risk factors for NASH (overweight, diabetes, metabolic syndrome).
This is based on a small observational study; clinical trials are needed before official recommendations.
low confidenceIf you have NASH, ask your doctor about testing fecal ethanol levels as part of monitoring.
Fecal ethanol testing is not yet standard and may not be commercially available.
medium confidenceAvoid unnecessary antibiotics that might disrupt gut microbiome balance.
Always follow medical advice; antibiotics are important for infections.
high confidenceWhy this study matters
The Alcohol-Making Bacteria
This study found four ethanol-producing bacteria enriched in NASH patients: Limosilactobacillus fermentum, Enterocloster bolteae, Mediterraneibacter gnavus, and Streptococcus mutans. Enterocloster bolteae was found in 43% of NASH patients but never in controls, giving it a 100% positive predictive value.
These bacteria could be a hidden cause of liver damage, suggesting new ways to diagnose or treat fatty liver disease by targeting gut microbes.
A Probiotic That Might Protect
Lacticaseibacillus casei, a common probiotic, was found in 30% of healthy controls but was completely absent in all 41 NASH patients. This suggests it may protect against NASH, possibly by interfering with ethanol production.
You can buy this probiotic at the store, and it might help prevent or even treat fatty liver disease—a simple, accessible intervention.
Fecal Ethanol as a Biomarker
Fecal ethanol was significantly higher in NASH patients (p=0.0145), with 11 out of 41 patients exceeding the maximum level seen in controls. No control had abnormal levels.
This means a simple stool test could potentially screen for NASH, reducing the need for invasive liver biopsies.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists studied poop from people with a liver disease called NASH and healthy people. They found that NASH patients have more alcohol (ethanol) in their stool, and certain bacteria that make alcohol are more common in NASH patients.
Research results
NASH patients had higher stool alcohol levels (11 out of 41 had abnormal levels vs 0 in controls). Four alcohol-making bacteria were found more often in NASH patients.
What this means - more context
This suggests that gut bacteria producing alcohol might contribute to liver damage in NASH.
To assess fecal ethanol and other biochemical parameters, characterize NASH-associated dysbiosis, and identify ethanol-producing gut microbes associated with the disease.
Fecal ethanol and glucose were elevated in NASH patients (p<0.05). Four ethanol-producing bacteria (Limosilactobacillus fermentum, Enterocloster bolteae, Mediterraneibacter gnavus, Streptococcus mutans) were enriched in NASH. Lactobacillus casei was absent in NASH, suggesting a protective role.
Methods Used
Case-control study: 41 NASH patients and 24 healthy controls. Fecal ethanol measured by HPLC. Viable bacteria assessed by culturomics (24 samples) and 16S amplicon sequencing (all samples).
Main Finding
Elevated fecal ethanol and enrichment of four ethanol-producing gut bacteria in NASH. Enterocloster bolteae had 100% positive predictive value, and Lactobacillus casei had 100% negative predictive value for NASH.
Confidence Level
Moderate: small sample size for culturomics, but complementary methods strengthen results.
Study Flags
Red Flags
- •Small sample size for culturomics (24 samples)
- •No blinding or randomization
- •Potential confounding factors not fully controlled
Surprising Findings
Enterocloster bolteae was detected only by culturomics, not by standard 16S sequencing.
It challenges the assumption that DNA sequencing is enough to identify all important microbes, showing old-school culture methods are still essential.
Practical Takeaways
Consider taking probiotics containing Lacticaseibacillus casei if you have risk factors for NASH (overweight, diabetes, metabolic syndrome).
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 543 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Human Case-Control
Subject
Moderate probability
on the GRADE evidence scale
This study looked at people with a liver disease called NASH and healthy people. They found that the sick people had more ethanol in their poop and more bacteria that make ethanol. But this type of study can only show that these things are linked; it can't prove that the bacteria cause the disease.
Strengths
- Use of two complementary methods (culturomics and 16S metagenomics) to identify bacteria.
- Inclusion of a control group.
- Statistical correction for multiple comparisons (though not explicitly stated, they used appropriate tests).
Weaknesses
- Case-control design cannot establish temporality or causation.
- Small sample size, especially for culturomics (24 samples).
- No blinding or randomization; potential selection bias.
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists studied poop from people with a liver disease called NASH and healthy people. They found that NASH patients have more alcohol (ethanol) in their stool, and certain bacteria that make alcohol are more common in NASH patients.
Research results
NASH patients had higher stool alcohol levels (11 out of 41 had abnormal levels vs 0 in controls). Four alcohol-making bacteria were found more often in NASH patients.
What this means - more context
This suggests that gut bacteria producing alcohol might contribute to liver damage in NASH.
To assess fecal ethanol and other biochemical parameters, characterize NASH-associated dysbiosis, and identify ethanol-producing gut microbes associated with the disease.
Fecal ethanol and glucose were elevated in NASH patients (p<0.05). Four ethanol-producing bacteria (Limosilactobacillus fermentum, Enterocloster bolteae, Mediterraneibacter gnavus, Streptococcus mutans) were enriched in NASH. Lactobacillus casei was absent in NASH, suggesting a protective role.
Methods Used
Case-control study: 41 NASH patients and 24 healthy controls. Fecal ethanol measured by HPLC. Viable bacteria assessed by culturomics (24 samples) and 16S amplicon sequencing (all samples).
Main Finding
Elevated fecal ethanol and enrichment of four ethanol-producing gut bacteria in NASH. Enterocloster bolteae had 100% positive predictive value, and Lactobacillus casei had 100% negative predictive value for NASH.
Confidence Level
Moderate: small sample size for culturomics, but complementary methods strengthen results.
Study Flags
Red Flags
- •Small sample size for culturomics (24 samples)
- •No blinding or randomization
- •Potential confounding factors not fully controlled
Surprising Findings
Enterocloster bolteae was detected only by culturomics, not by standard 16S sequencing.
It challenges the assumption that DNA sequencing is enough to identify all important microbes, showing old-school culture methods are still essential.
Practical Takeaways
Consider taking probiotics containing Lacticaseibacillus casei if you have risk factors for NASH (overweight, diabetes, metabolic syndrome).
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 543 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Human Case-Control
Subject
Moderate probability
on the GRADE evidence scale
This study looked at people with a liver disease called NASH and healthy people. They found that the sick people had more ethanol in their poop and more bacteria that make ethanol. But this type of study can only show that these things are linked; it can't prove that the bacteria cause the disease.
Strengths
- Use of two complementary methods (culturomics and 16S metagenomics) to identify bacteria.
- Inclusion of a control group.
- Statistical correction for multiple comparisons (though not explicitly stated, they used appropriate tests).
Weaknesses
- Case-control design cannot establish temporality or causation.
- Small sample size, especially for culturomics (24 samples).
- No blinding or randomization; potential selection bias.
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study compared two groups and used two different methods to find bacteria, which is good. But it only looked at people once, so we don't know what came first. Also, the group with NASH was small, and the healthy group might not have been perfectly healthy. So we should be careful about trusting the results too much.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
26 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=65)+5.5/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 543 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. Case-control studies can only identify associations, not causal relationships, due to lack of randomization, potential confounding, and inability to establish temporal sequence.
COI Unknown
Could not determine conflict of interest status
No funding or conflict of interest information provided in the text.
The text does not include a funding statement or conflict of interest declaration. Without this information, it is not possible to assess potential biases.